The founder-led sales framework we install for every client for healthcare and life sciences in Latin America
A repeatable, seven-part framework for running founder-led sales as a system — the same one we use inside every Growth Broker engagement. Written for commercial leaders at healthtech, medtech, and life-sciences companies in Latin America.
This edition of the Growth Broker playbook is written for commercial leaders at healthtech, medtech, and life-sciences companies operating in Latin America. In this market, LATAM buyers reward hands-on partnership, local presence, and clear commercial terms, so the way you install founder-led sales has to be shaped to that reality from day one.
We have installed founder-led sales inside more than fifty companies. This is the framework we reach for every time. Founder-led sales is the founder personally running discovery, closing, and post-sale for the first 100 customers, and the framework exists to keep that definition honest under real conditions.
Part one, diagnosis. Before you touch the model, name the constraint: finance, demand, access, or conversion. Founder-led sales applied to the wrong constraint is theatre.
Part two, target. Narrow to one industry, one role, one trigger. Every extra dimension halves conversion.
Inside healthcare and life sciences, the binding constraint is almost always regulated-sale cycle length, not intent, and in Latin America it is compounded by the fact that local partnership depth, not marketing spend is what actually gates growth. Founder-led sales is only useful here when it is pointed at both constraints at once.
Part three, offer. What is the buyer's next step, and what makes it obvious? The offer, not the copy, is what carries.
Part four, engine. Tools, sequences, data. Buy the minimum you can operate; every extra tool is a future dependency.
Part five, operating rhythm. Monday plan, Friday review, weekly founder hours per week in customer conversations. Nothing about the model is left to memory.
Parts six and seven, learning and allocation. What did we learn last week; where does next week's dollar go. Once those two loops are live, founder-led sales compounds and the framework stops being visible.
Concretely for healthcare and life sciences in Latin America: the healthcare teams that install this get past procurement instead of dying in it, and one properly-installed LATAM account becomes a reference across the region. That is the reason it is worth installing founder-led sales deliberately for this market rather than importing a playbook designed for somewhere else.
Frequently asked questions
Sales · healthcare · LATAM — answered
- Does founder-led sales work for healthcare and life sciences in Latin America?
- Yes — provided it is pointed at regulated-sale cycle length, not intent and adapted to the fact that in Latin America, LATAM buyers reward hands-on partnership, local presence, and clear commercial terms. The healthcare teams that install this get past procurement instead of dying in it.
- Do I need all seven parts to see results?
- Diagnosis, target, and operating rhythm are the non-negotiables. The others can lag by weeks, not quarters.
- How long does the framework take to install?
- Six to twelve weeks depending on the state of the data and the size of the team.
- Can I adapt the framework to my stack?
- The framework is stack-agnostic. Tooling is part four and is the most swappable piece.
- What is the biggest risk to the framework?
- Hiring VP of Sales at $500k ARR to escape sales — usually because a stakeholder shortcuts diagnosis to get to spend.
- What is the LATAM-specific pitfall when running founder-led sales for healthcare?
- Importing a playbook that was built for another market. In Latin America, LATAM buyers reward hands-on partnership, local presence, and clear commercial terms — the install has to reflect that.
Growth Broker editorial
Filed under sales · healthcare · latam